Ten years of human papillomavirus vaccination in the United States
LE Markowitz, J Gee, H Chesson, S Stokley - Academic pediatrics, 2018 - Elsevier
… Since human papillomavirus (HPV) vaccine was first introduced for females in the United
States in 2006, vaccination policy has evolved as additional HPV vaccines were licensed and …
States in 2006, vaccination policy has evolved as additional HPV vaccines were licensed and …
[HTML][HTML] Human papillomavirus vaccination: the population impact
L Lee, SM Garland - F1000Research, 2017 - ncbi.nlm.nih.gov
… Multivalent human papillomavirus vaccines. Some countries have implemented or have
plans to commence the use of 9vHPV vaccines to offer protection against the additional five next …
plans to commence the use of 9vHPV vaccines to offer protection against the additional five next …
Human papillomavirus vaccination
LE Markowitz, ER Unger - New England Journal of Medicine, 2023 - Mass Medical Soc
Key Clinical Points Human Papillomavirus Vaccination Human papillomavirus (HPV) is a
common sexually transmitted virus. Most HPV infections clear or become undetectable within 1 …
common sexually transmitted virus. Most HPV infections clear or become undetectable within 1 …
[HTML][HTML] Evaluating human papillomavirus vaccination programs
AV Taira, CP Neukermans… - Emerging infectious …, 2004 - ncbi.nlm.nih.gov
… effect of a male vaccination program on female human papillomavirus (HPV) infection rates
and cervical cancer incidence, we needed to directly model the effect of vaccination on HPV …
and cervical cancer incidence, we needed to directly model the effect of vaccination on HPV …
相关搜索
- human papillomavirus vaccination cervical cancer
- human papillomavirus vaccination adolescent
- human papillomavirus vaccination girls
- human papillomavirus vaccination rates
- human papillomavirus vaccination cost-effectiveness
- human papillomavirus vaccination coverage
- human papillomavirus vaccination men
- quadrivalent human papillomavirus vaccination
[HTML][HTML] Model for assessing human papillomavirus vaccination strategies
EH Elbasha, EJ Dasbach… - Emerging infectious …, 2007 - ncbi.nlm.nih.gov
We present a transmission dynamic model that can assess the epidemiologic consequences
and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent (…
and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent (…
[HTML][HTML] Opportunities and challenges for human papillomavirus vaccination in cancer
R Roden, PL Stern - Nature Reviews Cancer, 2018 - nature.com
… The licensed vaccines are safe and highly effective against the most common human
papillomavirus (HPV) types found in cervical and other anogenital cancers and are likely to prevent …
papillomavirus (HPV) types found in cervical and other anogenital cancers and are likely to prevent …
Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women
JA Kahn, SL Rosenthal, Y Jin, B Huang… - Obstetrics & …, 2008 - journals.lww.com
… beliefs about human papillomavirus vaccines and fewer practical barriers to vaccination are
… A quadrivalent human papillomavirus (HPV) vaccine was licensed by the US Food and Drug …
… A quadrivalent human papillomavirus (HPV) vaccine was licensed by the US Food and Drug …
Human papillomavirus vaccine introduction–the first five years
LE Markowitz, V Tsu, SL Deeks, H Cubie, SA Wang… - Vaccine, 2012 - Elsevier
… The availability of prophylactic human papillomavirus (HPV) vaccines has provided …
vaccines have each been licensed in over 100 countries. By the beginning of 2012, HPV vaccine …
vaccines have each been licensed in over 100 countries. By the beginning of 2012, HPV vaccine …
Present status of human papillomavirus vaccine development and implementation
R Herrero, P González, LE Markowitz - The Lancet Oncology, 2015 - thelancet.com
Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …
Human papillomavirus vaccination series initiation and completion, 2008–2009
CG Dorell, D Yankey, TA Santibanez… - Pediatrics, 2011 - publications.aap.org
OBJECTIVE: The goal was to describe factors associated with human papillomavirus (HPV)
vaccination series initiation (≥1 dose) and completion (≥3 doses) and parents' intent to …
vaccination series initiation (≥1 dose) and completion (≥3 doses) and parents' intent to …